1422.00GBp+1.43%Mkt Cap: 3.05B GBpP/E: 10.63Last update: 2026-05-13
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, specialty, and branded pharmaceutical products. The company operates through three segments: Injectables, Hikma Rx, and Branded. Th…
Industry Peers
Drug Manufacturers - Specialty & Generic153.14BSEKP/E 167.7
58.14BTRYP/E 27.8
51.02BEURP/E 20.1
13.68BEURP/E 31.2
13.35BTRY—
13.10BSEKP/E 39.5
3.09BTRY—
3.02BEURP/E 25.0
loading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)10.63
P/E (Forward)7.76
PEG1.71
P/B1.65
P/S0.92
EV/EBITDA5.40
EV/Revenue1.36
EPS (TTM)1.34
EPS (Forward)1.86
Cash Flow & Leverage
FCF Yield-2.17%
FCF Margin-1.97%
Operating CF436.00M GBp
CapEx (TTM)317.00M GBp
Net Debt/EBITDA1.62
Net Debt1.36B GBp
Technical
SMA 501326.66 (+7.2%)
SMA 2001554.27 (-8.5%)
Beta0.64
S&P 52W Chg24.23%
Avg Vol (30d)927.78K
Avg Vol (10d)703.31K
Technical Indicators
RSI (14)60.3
MACD24.1935
MACD Signal22.0873
MACD Hist.+2.1062
BB Upper1446.69 GBp
BB Middle1385.53 GBp
BB Lower1324.36 GBp
BB Width8.83%
ATR (14)37.99 GBp
Vol Ratio (20d)0.73x
52W Range
1187.0024% of range2164.00
52W High2164.00 GBp
52W Low1187.00 GBp
Profitability
Gross Margin43.03%
EBITDA Margin25.14%
Profit Margin12.00%
Oper. Margin16.20%
ROE15.50%
ROA7.09%
Revenue Growth8.50%
Earnings Growth23.50%
Balance Sheet
Debt/Equity0.62
Current Ratio1.82
Quick Ratio0.91
Book Value/Sh8.710 GBp
Cash/Share1.104 GBp
Dividends
Fwd Div Rate0.6200 GBp
Trail. Div Rate0.8400 GBp
Div. Yield4.29%
5Y Avg Yield2.77%
Payout Ratio46.49%
Ex-Div DateMar 19, 2026
Pay Date—
Ownership
Shares Out.214.37M
Float151.33M
Insiders31.70%
Institutions45.88%
Analyst Consensus
Rating1.5 (Buy)
Target (Mean)1915.69 GBp
Target Range1363.64 GBp – 2660.77 GBp
# Analysts11
Company
Market Cap3.05B GBp
Enterprise Value4.54B GBp
Revenue (TTM)3.35B GBp
Gross Profit1.44B GBp
Net Income (TTM)402.00M GBp
Revenue/Share15.18 GBp
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees9.4K
Last Price1422.00 GBp
CountryGB
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—